[Classification, etiology, diagnosis and treatment of prostatitis. Other types of prostatitis. Acute and chronic prostatitis].
Prostatitis is a highly prevalent nosologic entity and hence has an enormous financial impact on health systems as well as negative repercussions on patients' quality of life. The symptoms are ambiguous, diagnostic methods are controversial and treatments are long and produce inconsistent results; consequently, although not life-threatening, prostatitis has become one of those diseases that is difficult both for the patient and for the physician who attempts to help, sometimes without success. Although an infectious etiology is accepted in most cases, there are major controversies about both the diagnostic methods used and their interpretation. Recently the National Institutes of Health in the USA has proposed a new classification of this disease to substitute that used for the last twenty years. This new classification may provide a more effective approach to the diagnosis and treatment of this insidious disease.
Jiménez-Cruz
Juan Fernando
JF
Servicio de Urología, Hospital Universitario La Fe, Valencia, España.
Broseta-Rico
Enrique
E
D000208:Acute Disease; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy; D019090:Case Management; D002908:Chronic Disease; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009316:National Institutes of Health (U.S.); D010173:Palpation; D017699:Pelvic Pain / Q000145:classification / Q000188:drug therapy / Q000209:etiology; D015995:Prevalence; D011472:Prostatitis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D012661:Semen / Q000166:cytology / Q000382:microbiology; D014481:United States; D014563:Urodynamics
D000317:Adrenergic alpha-Antagonists; D000900:Anti-Bacterial Agents